The major limitation of the thiazolidinediones in the treatment of type 2 diabetes mellitus is:

• A. Frequent hypoglycaemic episodes
• B. Hyperinsulinemia
• C. Lactic acidosis
• D. Low hypoglycaemic efficacy in moderate to severe cases